Avadel Pharmaceuticals PLC (AVDL) stock news · rev $169.1M
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
This AVDL news page leads with what Avadel Pharmaceuticals PLC filed — not a scraped headline mill.
No cached 8-K sentence for AVDL yet. We will not pad this page with generic market recap.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the AVDL stock page; for the tape open the quote page.
AVDL stock news FAQ
What are AVDL's latest revenue and net income?
Latest cached Avadel Pharmaceuticals PLC (AVDL) revenue for Dec 31, 2024 was $169.1M. Net income was -$48.8M. Statements: https://lician.com/financials/avdl
How did AVDL revenue change from the prior cached period?
Cached Avadel Pharmaceuticals PLC (AVDL) revenue was up 504.8% from $28.0M (Dec 31, 2023) to $169.1M (Dec 31, 2024). Statements: https://lician.com/financials/avdl
What is AVDL's market cap?
Avadel Pharmaceuticals PLC (AVDL) market cap is $968.5M on the latest cached fundamentals snapshot.
What kind of company is AVDL?
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
Where is AVDL stock news listed?
Cached stock news for Avadel Pharmaceuticals PLC (AVDL) is listed at https://lician.com/news/avdl. Filings: https://lician.com/sec/avdl
Not investment advice.